Showing results (4301-4310 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|March 28, 2017
Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recoveryIsaac Rosado-Sánchez, Inmaculada Jarrín, María M Pozo-Balado, et al.Antiviral Research|April 1, 2014
Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screeningMichael K Lo, Stuart T Nichol, Christina F SpiropoulouAntiviral Research|April 1, 2014
A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmissionRuiping Wu, Xingxing Li, Ho-Chuen Leung, et al.Antiviral Research|April 1, 1989
Inhibition of HIV replication by liposomal encapsulated amphotericin BD R Pontani, D Sun, J W Brown, et al.Antiviral Research|April 15, 2014
Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Youngmin A Lee, Scott L FriedmanAntiviral Research|April 22, 2014
Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypesAxel Schubert, Eva Gentner, Kathrin Bohn, et al.Antiviral Research|February 15, 2014
Entry inhibitors and future treatment of hepatitis CIsabel Fofana, Nikolaus Jilg, Raymond T Chung, et al.Antiviral Research|March 1, 2014
A dihydro-pyrido-indole potently inhibits HSV-1 infection by interfering the viral immediate early transcriptional eventsParomita Bag, Durbadal Ojha, Hemanta Mukherjee, et al.Antiviral Research|March 4, 2014
Determining anti-betanodavirus compounds through a GF-1 cell-based screening platformYi-Cheng Huang, Yu-San HanAntiviral Research|March 6, 2014
Telaprevir or boceprevir based therapy for chronic hepatitis C infection: development of resistance-associated variants in treatment failureMalcolm J Macartney, Dianne Irish, Simon H Bridge, et al.Pageof 523